Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.
Linkins
K W
KW
Lloyd
J R
JR
Hjelmstad
G O
GO
Strausbaugh
H J
HJ
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics*; D002219:Carbamates / Q000191:economics* / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D017046:Cost Savings; D006801:Humans; D018696:Neuroprotective Agents / Q000191:economics* / Q000627:therapeutic use*; D048448:Phenylcarbamates; D000068836:Rivastigmine
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D000068836:Rivastigmine